Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO0503821 once-monthly versus darbepoetin alfa in non-dialysis chronic kidney disease anemia
2006-004552-21Phase 3Completed
- Sponsor
- Roche
- Start
- Nov 2006
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Uraemic Anaemia comparing Mircera once monthly with Darbepoetin alfa according to local label (2 arms). Started Nov 2006; status: completed.
02
Drugs
Epoetin alfa RBdarbepoetin alfa
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on 2006-004552-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004552-21.